Galli M, Ten Berg J, Berry C. Meta-analyses limitations and the compelling case for a contemporary, pragmatic trial of clopidogrel vs aspirin for secondary prevention of coronary heart disease: clopidogrel is not superior to aspirin in non-East Asian patients. Eur Heart J 2026 Oct 10:ehag805. doi: 10.1093.
PMID: 42856047